首页> 外文OA文献 >Comparative Efficacy of Combined Radiotherapy, Systemic Therapy, and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer: A Network Meta-Analysis and Systematic Review

【2h】

Comparative Efficacy of Combined Radiotherapy, Systemic Therapy, and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer: A Network Meta-Analysis and Systematic Review

机译：联合放疗，全身治疗和雄激素剥夺治疗转移激素敏感前列腺癌的比较疗效：网络元分析和系统综述

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yuhan Wang; Huiming Gui; Juan Wang; Junqiang Tian; Hanzhang Wang; Chaozhao Liang; Zongyao Hao; Ronald Rodriguez; Zhiping Wang;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Androgen-deprivation therapy plus chemotherapy in metastatic hormone-sensitive prostate cancer. A systematic review and meta-analysis of randomized clinical trials [J] . Ramos-Esquivel Allan, Fernandez Cristina, Zeledon Zenen Urologic oncology . 2016,第8期

机译：雄激素剥夺疗法加化疗治疗转移性激素敏感性前列腺癌。随机临床试验的系统评价和荟萃分析
2. Abiraterone acetate/androgen deprivation therapy combination versus docetaxel/androgen deprivation therapy combination in advanced hormone-sensitive prostate cancer: a network meta-analysis on safety and efficacy [J] . Kassem Loay, Shohdy Kyrillus S., Abdel-Rahman Omar Current medical research and opinion . 2018,第5期

机译：AbiraTerone醋酸盐/雄激素剥夺治疗组合与多西紫杉醇/雄激素剥夺治疗组合在晚期激素敏感前列腺癌中：网络元分析安全性和疗效
3. Response to letter commenting on published paper: Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis [J] . Rydzewska Larysa H. M., Burdett Sarah, Vale Claire L., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：对发表论文的信封评论的回应：将AbiraTerone添加到具有转移激素敏感前列腺癌的男性中的雄激素剥夺治疗：系统评价和荟萃分析
4. Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients [C] . A. Komiya, K. Ichimatsu, A. Morii, International Congress of Andrology . 2009

机译：日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
5. Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy [D] . TAKEI, Akinori 2019

机译：雄激素剥夺治疗的持续时间和最低20 ng / dL的睾丸激素最低值可预测接受外照射的前列腺癌患者的睾丸激素恢复至超水平
6. Comparative Efficacy of Combined Radiotherapy Systemic Therapy and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer: A Network Meta-Analysis and Systematic Review [O] . Yuhan Wang, Huiming Gui, Juan Wang, 2020

机译：联合放疗全身治疗和雄激素剥夺治疗转移激素敏感前列腺癌的比较疗效：网络元分析和系统综述
7. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis [O] . Rydzewska Larysa H.M., Burdett Sarah, Vale Claire L., 2017

机译：转移性激素敏感性前列腺癌男性雄激素剥夺治疗中加入阿比特龙：系统评价和荟萃分析
8. MR Guided Pulsed High Intensity Focused Ultrasound Enhancement of Gene Therapy Combined with Androgen Deprivation and Radiotherapy for Prostate Cancer Treatment. [R] . Chen, L. 2012

机译：mR引导脉冲高强度聚焦超声增强基因疗法结合雄激素剥夺和放射治疗前列腺癌治疗。

Comparative Efficacy of Combined Radiotherapy, Systemic Therapy, and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer: A Network Meta-Analysis and Systematic Review

著录项

相似文献

相关主题

期刊订阅